Premature Ejaculation Treatment in New Jersey

What Is Premature Ejaculation?

If you are looking for premature ejaculation treatment in New Jersey, Princeton Men’s Health offers a physician-directed combination approach — and a proper clinical evaluation most men with this condition have never had. It is defined clinically as ejaculation that occurs sooner than the man or his partner would prefer, with minimal stimulation, and which causes personal distress or interpersonal difficulty.

There are two distinct presentations. Lifelong premature ejaculation has been present since the first sexual experiences and typically has a strong neurological or genetic component. Acquired premature ejaculation develops after a period of normal function and is more commonly associated with hormonal changes, relationship factors, anxiety, or an underlying medical condition such as prostatitis or erectile dysfunction.

The distinction matters because it affects treatment. A man with lifelong PE and a man who developed it in his 40s alongside declining testosterone are dealing with different clinical pictures — and need different approaches.

Despite how common it is, most men with premature ejaculation never discuss it with a physician. The result is years of avoidance, relationship strain, and reduced sexual confidence that is in the majority of cases entirely addressable with proper evaluation and treatment.

What Causes Premature Ejaculation?

Premature ejaculation is not a single condition with a single cause. It sits at the intersection of neurological, hormonal, psychological, and vascular factors — which is precisely why a single-treatment approach so frequently falls short.

Neurological and sensitivity factors

The ejaculatory reflex is controlled by serotonin pathways in the brain. Men with lower serotonin activity in these pathways have a shorter ejaculatory latency — a biological predisposition that is not a character flaw or a psychological weakness. Penile hypersensitivity — where the nerve endings in the glans are unusually reactive — is a common contributing factor, particularly in lifelong PE.

Hormonal factors

Testosterone plays a direct role in ejaculatory control. Low testosterone is associated with reduced ejaculatory latency in some men — meaning that as testosterone declines, the time to ejaculation shortens. This is one of the most commonly missed connections in PE evaluation. Men who present with both low testosterone and premature ejaculation frequently see improvement in ejaculatory control when testosterone is optimised alongside other treatments. Thyroid dysfunction is also associated with premature ejaculation and is worth screening for in any comprehensive evaluation.

Psychological factors

Performance anxiety, relationship stress, depression, and a history of sexual trauma can all contribute to or maintain premature ejaculation. These factors do not make PE less real or less treatable — but they need to be part of the evaluation rather than assumed to be the only cause.

Vascular and erectile factors

There is a well-established overlap between premature ejaculation and erectile dysfunction. Men with ED frequently develop PE as a compensatory response — ejaculating quickly to maintain the erection before it is lost. Addressing the underlying erectile dysfunction often improves ejaculatory control simultaneously.

Premature Ejaculation Treatment New Jersey — The Combination Approach

Because premature ejaculation involves multiple contributing pathways, the most effective treatment addresses several of them simultaneously. Dr. Siddique’s combination approach draws on six evidence-informed interventions, selected and sequenced based on the individual patient’s evaluation findings.

Topical anaesthetic therapy

Lidocaine-based topical creams or sprays applied to the glans before intercourse reduce penile sensitivity and extend ejaculatory latency. They are fast-acting, effective, and well-tolerated. For men with penile hypersensitivity as a primary driver, topical therapy alone can produce significant improvement. In combination with other approaches it extends the window for other treatments to take effect.

Pharmacological management — SSRIs and dapoxetine

Selective serotonin reuptake inhibitors (SSRIs) are the most evidence-based pharmacological treatment for premature ejaculation. They work by increasing serotonin activity in the ejaculatory control pathways, extending latency time. Dapoxetine is a short-acting SSRI specifically developed for on-demand use in PE. Daily SSRIs are an alternative for men who prefer a consistent effect. Both are prescribed based on the individual presentation. The International Society for Sexual Medicine recognizes SSRIs as a first-line pharmacological option for premature ejaculation.

PDE5 inhibitors

Medications such as sildenafil (Viagra) and tadalafil (Cialis) are primarily used for erectile dysfunction but have a well-documented secondary benefit in premature ejaculation — particularly in men where ED and PE coexist. They reduce performance anxiety, improve erectile confidence, and appear to have a direct effect on ejaculatory latency. In the combination approach they are particularly useful where both conditions are present.

Platelet-Rich Plasma (PRP)

Autologous platelet-rich plasma — drawn from the patient’s own blood and reinjected into targeted penile tissue — delivers growth factors that support nerve function, vascular health, and tissue sensitivity calibration. PRP for premature ejaculation is performed off-label, based on clinical judgement and the available evidence. Patients should understand the distinction before proceeding. It is typically used as part of the combination protocol rather than as a standalone treatment.

Focused shockwave therapy

Low-intensity focused shockwave therapy delivered to the penile tissue promotes neovascularisation — new blood vessel growth — and has evidence for improving both erectile function and ejaculatory control. In the context of PE it is particularly useful where vascular factors or ED overlap with premature ejaculation. The same protocol used for vasculogenic ED is applied, typically six sessions over three to six weeks.

Behavioural techniques and pelvic floor training

Pelvic floor dysfunction — specifically overactive or poorly controlled pelvic floor muscles — is a frequently overlooked contributor to premature ejaculation. Pelvic floor rehabilitation, breathing techniques, and structured behavioural approaches are integrated into the treatment plan where indicated. These are not offered as standalone treatments but as components of the combination approach that address the neuromuscular dimension of ejaculatory control.

Individual results vary. The combination and sequencing of treatments is determined by Dr. Siddique based on your specific evaluation findings — not a standing protocol.

What to Expect From Treatment

Timeline

Some components of the combination approach — topical therapy and PDE5 inhibitors — produce results quickly, often within the first few uses. SSRIs typically take two to four weeks to reach full effect. PRP and focused shockwave therapy produce results over weeks to months as the biological repair processes develop. The combination approach is designed so that faster-acting treatments provide immediate improvement while longer-acting biological treatments build toward more durable results.

Monitoring and adjustment

Treatment response is reviewed at follow-up appointments. The combination is adjusted based on what is working and what is not — doses are refined, treatments added or discontinued, and the plan evolved as your response becomes clear. This is ongoing physician management, not a one-time prescription.

What patients typically experience

Most men notice meaningful improvement in ejaculatory control within the first month of treatment. The degree of improvement and the timeline vary significantly between individuals depending on the contributing factors, baseline severity, and adherence to the protocol. Individual results vary.

Discretion

Every consultation and treatment session at Princeton Men’s Health is completely private. Dr. Siddique sees patients personally. There is no waiting room disclosure, no shared treatment spaces, and no staff involvement beyond what is clinically necessary.

Dr. Siddique on Premature Ejaculation Treatment

Dr. Siddique discusses the combination approach to premature ejaculation — addressing neurological, hormonal, vascular, and behavioural factors simultaneously. Video coming soon.

Dr. Siddique discusses premature ejaculation evaluation and treatment at Princeton Men’s Health.

Is This Right for You?

Princeton Men’s Health provides premature ejaculation treatment in New Jersey from our clinic in Lawrence Township — minutes from Princeton, Hamilton, and West Windsor.

If premature ejaculation is affecting your quality of life, your relationship, or your sexual confidence — and you have never had a proper clinical evaluation — that evaluation is worth having.

The men who benefit most from this approach are those who:

  • Have tried single treatments without satisfactory results
  • Suspect a hormonal or vascular component alongside the ejaculatory issue
  • Have both PE and ED and want both addressed together
  • Want a physician-directed approach rather than an online prescription service

You do not need a referral. You do not need a prior diagnosis. You need a consultation with a physician who can evaluate the full picture.

Princeton Men’s Health is located at 31 East Darrah Lane in Lawrence Township, New Jersey — minutes from Princeton, Hamilton, West Windsor, and the surrounding Mercer County area.

Frequently Asked Questions

How common is premature ejaculation?

Premature ejaculation is the most common male sexual dysfunction, affecting an estimated one in three men at some point in their lives. Despite how common it is, most men never discuss it with a physician. It is a medical condition with identifiable causes and effective treatments — not a personal failing or something that has to be managed alone.

What causes premature ejaculation?

Premature ejaculation typically involves a combination of neurological, hormonal, psychological, and vascular factors. Neurological predisposition — lower serotonin activity in ejaculatory control pathways — is common in lifelong PE. Low testosterone and thyroid dysfunction are hormonal contributors that are frequently missed. Erectile dysfunction and PE frequently coexist and reinforce each other. Performance anxiety and relationship stress maintain the condition even when the original cause was biological. A proper evaluation identifies which factors are present in your specific case.

What treatments are available for premature ejaculation?

Princeton Men’s Health offers a combination approach that draws on six evidence-informed treatments: topical anaesthetic therapy, SSRIs and dapoxetine, PDE5 inhibitors, platelet-rich plasma, focused shockwave therapy, and behavioural and pelvic floor techniques. The combination and sequencing is determined by Dr. Siddique based on your individual evaluation findings. Individual results vary.

How long does treatment take to work?

It depends on the components used. Topical therapy and PDE5 inhibitors produce results quickly — often within the first few uses. SSRIs typically take two to four weeks to reach full effect. PRP and focused shockwave therapy produce results over weeks to months as biological repair processes develop. The combination approach is designed so faster-acting treatments provide immediate improvement while longer-acting treatments build toward more durable results. Individual results vary.

Is the consultation private?

Completely. Every consultation at Princeton Men’s Health is private and confidential. Dr. Siddique sees patients personally. Nothing about your visit is shared without your explicit consent. The clinic is a private physician practice — not a walk-in clinic or shared facility.

How do I get started?

Call Princeton Men’s Health at (844) 513-2150 or use the booking form on our contact page to schedule a consultation with Dr. Siddique. No referral is required. Every evaluation begins with a thorough clinical assessment before any treatment is recommended or prescribed.